INTRODUCTION: The risk of coronavirus disease-19 infection for healthcare professionals and patients in hospitals remains unclear.
METHODS: We investigated whether precautions adopted in our inflammatory bowel disease (IBD) unit have minimized the risks of infection for all patients accessing our facilities in a 1-month period by assessing the rate of coronavirus disease-19 infection in the follow-up period.
RESULTS: Three hundred-twenty patients with IBD were included. None were infected from severe acute respiratory syndrome-coronavirus 2 in the follow-up period. None of the IBD team members were infected.
DISCUSSION: Neither pharmacological immunosuppression nor access to the hospital seem to be risk factors for infection in patients with IBD.
- Aged, 80 and over
- COVID-19 Testing
- Clinical Laboratory Techniques/statistics & numerical data
- Coronavirus Infections/diagnosis
- Follow-Up Studies
- Health Services Accessibility/statistics & numerical data
- Hospital Units/statistics & numerical data
- Immunosuppressive Agents/adverse effects
- Infection Control/statistics & numerical data
- Infectious Disease Transmission, Patient-to-Professional/prevention & control
- Infectious Disease Transmission, Professional-to-Patient/prevention & control
- Inflammatory Bowel Diseases/drug therapy
- Middle Aged
- Pandemics/prevention & control
- Pneumonia, Viral/diagnosis
- Risk Factors
- Young Adult